This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Sep;69(9):791-2.

doi: 10.1136/thoraxjnl-2014-205892. Epub 2014 Jul 4.

Hot off the breath: A big step forward for idiopathic pulmonary fibrosis

Christopher J Ryerson¹, Harold R Collard²

Affiliations

Affiliations

¹ Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
² Department of Medicine, University of California, San Francisco, San Francisco, California, USA.

PMID: 24996636
DOI: 10.1136/thoraxjnl-2014-205892

Editorial

Hot off the breath: A big step forward for idiopathic pulmonary fibrosis

Christopher J Ryerson et al. Thorax. 2014 Sep.

. 2014 Sep;69(9):791-2.

doi: 10.1136/thoraxjnl-2014-205892. Epub 2014 Jul 4.

Authors

Christopher J Ryerson¹, Harold R Collard²

Affiliations

¹ Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
² Department of Medicine, University of California, San Francisco, San Francisco, California, USA.

PMID: 24996636
DOI: 10.1136/thoraxjnl-2014-205892

No abstract available

Keywords: Idiopathic pulmonary fibrosis; Interstitial Fibrosis.

PubMed Disclaimer

Similar articles

[Antifibrotic treatment].
von der Beck D, Löh B, Drakopanagiotakis F, Markart P, Günther A. von der Beck D, et al. Dtsch Med Wochenschr. 2014 Dec;139(49):2523-5. doi: 10.1055/s-0034-1387450. Epub 2014 Nov 25. Dtsch Med Wochenschr. 2014. PMID: 25423462 Review. German. No abstract available.
Novel treatments for idiopathic pulmonary fibrosis.
Spagnolo P. Spagnolo P. Am J Med. 2015 May;128(5):447-9. doi: 10.1016/j.amjmed.2015.01.003. Epub 2015 Jan 20. Am J Med. 2015. PMID: 25613299 No abstract available.
Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions.
Raghu G, Selman M. Raghu G, et al. Am J Respir Crit Care Med. 2015 Feb 1;191(3):252-4. doi: 10.1164/rccm.201411-2044ED. Am J Respir Crit Care Med. 2015. PMID: 25635489 No abstract available.
[Idiopathic pulmonary fibrosis: A new era, new challenges].
Cottin V. Cottin V. Rev Mal Respir. 2014 Sep;31(7):583-6. doi: 10.1016/j.rmr.2014.07.009. Rev Mal Respir. 2014. PMID: 25239578 French. No abstract available.
Clinical trial research in focus: why do so many clinical trials fail in IPF?
Spagnolo P, Maher TM. Spagnolo P, et al. Lancet Respir Med. 2017 May;5(5):372-374. doi: 10.1016/S2213-2600(17)30122-4. Epub 2017 Apr 12. Lancet Respir Med. 2017. PMID: 28412184 Review. No abstract available.

See all similar articles

Cited by

Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
Aravena C, Labarca G, Venegas C, Arenas A, Rada G. Aravena C, et al. PLoS One. 2015 Aug 26;10(8):e0136160. doi: 10.1371/journal.pone.0136160. eCollection 2015. PLoS One. 2015. PMID: 26308723 Free PMC article.
Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses.
Guyard A, Danel C, Théou-Anton N, Debray MP, Gibault L, Mordant P, Castier Y, Crestani B, Zalcman G, Blons H, Cazes A. Guyard A, et al. Respir Res. 2017 Jun 15;18(1):120. doi: 10.1186/s12931-017-0605-y. Respir Res. 2017. PMID: 28619094 Free PMC article.
Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis.
Keating GM. Keating GM. Drugs. 2015 Jul;75(10):1131-40. doi: 10.1007/s40265-015-0418-6. Drugs. 2015. PMID: 26063212 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations